Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Madrigal Pharmaceuticals Inc fell by 231.63m. Cash Flow from Financing totalled 595.12m or -- of revenues. In addition the company used 324.23m for operations while cash used for investing totalled 502.52m.
Cash flow per share | -25.60 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 39.50 |
---|---|
Tangible book value per share | 39.27 |
More ▼
Balance sheet in USDView more
Current ratio | 8.72 |
---|---|
Quick ratio | 8.67 |
Total debt/total equity | 0.136 |
---|---|
Total debt/total capital | 0.1198 |
More ▼